{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459957208
| IUPAC_name = ''N''-benzyl-''N'',''N''-dimethyl-2-phenoxyethanaminium 3-hydroxynaphthalene-2-carboxylate
| image = Bephenium.png
| drug_name = 

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = Undefined
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability = <1%
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion = Renal (negligible)

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 7181-73-9
| CAS_supplemental = <br>{{CAS|3818-50-6}} (hydroxynaphtoate)
| ATC_prefix = P02
| ATC_suffix = CX02
| PubChem = 19667
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 18524
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 47RU9546DX
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1673148

<!--Chemical data-->
| C=17 | H=22 | N=1 | O=1 | charge = +
| molecular_weight = 256.36 g/mol
| smiles = O(c1ccccc1)CC[N+](Cc2ccccc2)(C)C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C17H22NO/c1-18(2,15-16-9-5-3-6-10-16)13-14-19-17-11-7-4-8-12-17/h3-12H,13-15H2,1-2H3/q+1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = AVWWVJUMXRXPNF-UHFFFAOYSA-N
}}

'''Bephenium hydroxynaphthoate''' ([[International Nonproprietary Name|INN]], trade names '''Alcopara''', '''Alcopar''', '''Befenium''', '''Debefenium''', '''Francin''', '''Nemex''') is an [[anthelmintic]] agent formerly used in the treatment of [[hookworm]] infections and [[ascariasis]].<ref name=Martindale>{{cite book |editor=Sweetman S |title=[[Martindale: The complete drug reference]] |edition=36th |location=London |publisher=Pharmaceutical Press |year=2009 |pages=143 |isbn=978-0-85369-840-1}}</ref><ref>{{cite journal |vauthors=Jayewardene G, Ismail MM, Wijayaratnam Y |title=Bephenium hydroxynaphthoate in treatment of ascariasis |journal=Br Med J |volume=2 |issue=5194 |pages=268â€“71 |date=July 1960 |pmid=14406934 |pmc=2097409 |doi=10.1136/bmj.2.5194.268}}</ref>

Bephenium is not FDA-approved and is not available in the United States.<ref name=POC-IT>{{cite web |url=http://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540057/all/Bephenium_hydroxynaphthoate |title=Bephenium hydroxynaphthoate  |author=Pham PA |date=March 19, 2009 |work=Point-of-Care Information Technology ABX Guide |publisher=[[Johns Hopkins University]]}} Retrieved on March 25, 2011.</ref>

==References==
{{Reflist}}

{{Anthelmintics}}
{{Nicotinic acetylcholine receptor modulators}}

[[Category:Antiparasitic agents]]
[[Category:Quaternary ammonium compounds]]
[[Category:Phenol ethers]]
[[Category:Benzyl compounds]]
[[Category:Nicotinic agonists]]

{{antiinfective-drug-stub}}